TearScience LipiView II Ocular Surface Interferometer

TearScience™ LipiView™ II Ocular Surface Interferometer

Leading innovation in lipid layer thickness measurement and meibomian gland imaging.

TearScience™ LipiView™ II Ocular Surface Interferometer

Leading innovation in lipid layer thickness measurement and meibomian gland imaging.

Key Features

Nanometer accuracy

Measures lipid layer thickness (LLT), captures blink dynamics and images meibomian gland structure.

Patented technology

Provides a sophisticated assessment of factors that contribute to dry eye.

Education opportunity

Visuals can be used to inform patients about their personal ocular health.

Dynamic meibomian imaging

Images for illustrative purposes only. Actual results may vary.

TearScience™ LipiScan™ Dynamic illumination

Dynamic Illumination

Surface lighting originates from multiple light sources to minimize reflection.

TearScience™ LipiScan™ Adaptive transillumination

Adaptive Transillumination

Changes to the light intensity across the surface of the illuminator compensate for the lid thickness variations between patients.

TearScience™ LipiScan™ Dual-mode DMI

Dual-Mode DMI

Dynamic Illumination offers an enhanced view of meibomian gland structure

TearScience™ LipiView™ II Reporting offers real-time visualization.

TearScience LipiView II Reporting

REAL-TIME VISUALIZATION

Lipid Layer Thickness (LLT) Evaluation with Nanometer Accuracy
Presents lipid layer thickness measurements in an easy to understand color-coded map.

Dynamic Meibomian Gland Imaging
Utilizes advanced illumination technology to capture high-definition images.

Blink Dynamics
Analyzes blink patterns and detects partial blinks. A graphical representation shows fluctuations in lipid layer thickness measurements between each blink.

Additional product benefits

TearScience LipiView II Features

  • Real-time visualization of the lipid layer to evaluate the dynamic response of lipids to blinking1
  • Video and analysis of blink dynamics
  • High-definition imaging with Dynamic Meibomian Imaging1

Visualize Blink Response


High-resolution video depicts how well ocular lipids disperse in response to a blink through variations in light patterns reflected off the tear film called an interferogram.

Feature Comparison

LipiScanLipiView II

Dynamic Meibomian Imaging (DMI)

Chin Sensory Position

Lipid Layer Thickness Assessment

Partial Blink Detection

Learn More

Get the latest news and product info from Johnson & Johnson Vision.

Required fields are marked with an asterisk *

*

*

*

*

Your Role

*

*

Area of Interest

*

Cataract Surgery

OS Disease

LASIK Surgery

Send me updates and helpful resources via email

*

With your consent, we will use your information to send you information about our products and services tailored to your interests through email. You may withdraw your consent at any time.

Please read our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SUMMARY OF IMPORTANT SAFETY INFORMATION

Rx Only
FOR THE TEARSCIENCE LIPIVIEW II OCULAR SURFACE INTERFEROMETER

INDICATIONS FOR USE
The TearScience LipiView II Ocular Surface Interferometer is an ophthalmic imaging device that is intended for use by a physician in adult patients to capture, archive, manipulate and store digital images of:

  • Specular (interferometric) observations of the tear film. Using these images, TearScience LipiView II measures the absolute thickness of the tear film lipid layer.
  • Meibomian glands under near-infrared (NIR) illumination.
  • The ocular surface and eyelids under white illumination.

CONTRAINDICATIONS
Contraindications are conditions in which the device should not be used because the risk of use clearly outweighs any benefit. No contraindications have been identified for TearScience LipiView II.

PRECAUTIONS
The following patient conditions may affect the interferometry assessment of a patient’s tear film using TearScience LipiView II:

  • Use of ophthalmic drops such as artificial tear lubricants, ointments, and medications. Advise patients not not instill oil-based ophthalmic drops (e.g., Soothe®, Restasis®, Systane® Balance) for at least 12 hours prior to device use and not to instill ointments for at least 24 hours prior to device use. Wait at least four (4) hours after the instillation of all other ophthalmic drops prior to device use.
  • Soft or rigid contact lens wear. Advise patients to remove contact lenses at least four hours prior to device use.
  • Use of oil-based facial cosmetics around the eye.
  • Eye rubbing.
  • Recent swimming in a chlorinated pool. Advise patients to not to swim for at least 12 hours prior to device use.
  • Any ocular surface condition that affects the stability of the tear film. These conditions include disease, dystrophy, trauma, scarring, surgery, or abnormality.

POTENTIAL ADVERSE EFFECTS
There are no known or anticipated adverse effects associated with use of this device.
Third party trademarks are the property of their respective owners.

PP2023OTH5148

Johnson & Johnson MedTech

We support the AdvaMed Code of Ethics on interacting with Healthcare Professionals.

Advamed Logo

© Johnson & Johnson Vision Care, Inc. and Johnson & Johnson Surgical Vision, Inc. 2024 All rights reserved. This site is published by Johnson & Johnson Vision Care, Inc. and Johnson & Johnson Surgical Vision, Inc., which are solely responsible for its content.

Third party trademarks used herein are trademarks of their respective owners.

Vision Made Possible